Karthik Radhakrishnan - Chief Financial Officer at Monopar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
MNPR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Karthik Radhakrishnan since 12/23/2023

Holdings reported by Karthik Radhakrishnan for Monopar Therapeutics

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.55K $10.4K $6.74 Oct 28, 2024 Direct
Stock Options 125K Jul 1, 2024 Direct Commom Stock

Transactions reported by Karthik Radhakrishnan for Monopar Therapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.